JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Financials Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Equities
002223
CNE1000009X3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.66 CNY | +0.79% |
|
+2.61% | +14.69% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 20,370 | 28,280 | 37,427 | 31,529 | 34,221 | 39,739 | - | - |
| Enterprise Value (EV) 1 | 18,957 | 28,280 | 37,427 | 31,529 | 34,221 | 39,739 | 39,739 | 39,739 |
| P/E ratio | 27.1 x | 16.1 x | 25.4 x | 19.8 x | 14.3 x | 17.5 x | 15.3 x | 13.1 x |
| Yield | 1.97% | 1.06% | 0.79% | 1.88% | 2.31% | 1.92% | 1.83% | 2.6% |
| Capitalization / Revenue | 4.39 x | 4.2 x | 5.43 x | 4.44 x | 4.29 x | 4.52 x | 3.84 x | 3.48 x |
| EV / Revenue | 4.39 x | 4.2 x | 5.43 x | 4.44 x | 4.29 x | 4.52 x | 3.84 x | 3.48 x |
| EV / EBITDA | 21.1 x | 12.7 x | 19.5 x | 15.2 x | 10.9 x | 15.4 x | 13.4 x | 11.3 x |
| EV / FCF | 116,866,821 x | 13,134,419 x | 40,819,814 x | - | - | - | - | - |
| FCF Yield | 0% | 0% | 0% | - | - | - | - | - |
| Price to Book | 3.36 x | 3.8 x | 4.58 x | 3.24 x | 2.95 x | 2.95 x | 2.53 x | 2.2 x |
| Nbr of stocks (in thousands) | 1,002,477 | 1,002,477 | 990,127 | 989,625 | 989,625 | 1,002,004 | - | - |
| Reference price 2 | 20.32 | 28.21 | 37.80 | 31.86 | 34.58 | 39.66 | 39.66 | 39.66 |
| Announcement Date | 2/28/20 | 1/28/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,636 | 6,726 | 6,894 | 7,102 | 7,972 | 8,800 | 10,347 | 11,415 |
| EBITDA 1 | 966.9 | 2,224 | 1,917 | 2,079 | 3,131 | 2,575 | 2,959 | 3,518 |
| EBIT 1 | 849.9 | 2,010 | 1,688 | 1,842 | 2,893 | 2,661 | 3,032 | 3,558 |
| Operating Margin | 18.33% | 29.88% | 24.48% | 25.93% | 36.3% | 30.24% | 29.3% | 31.17% |
| Earnings before Tax (EBT) 1 | 864.3 | 2,019 | 1,702 | 1,842 | 2,849 | 2,657 | 3,027 | 3,545 |
| Net income 1 | 752.6 | 1,759 | 1,482 | 1,595 | 2,396 | 2,271 | 2,595 | 3,040 |
| Net margin | 16.23% | 26.15% | 21.5% | 22.46% | 30.05% | 25.81% | 25.08% | 26.63% |
| EPS 2 | 0.7500 | 1.750 | 1.490 | 1.610 | 2.410 | 2.266 | 2.589 | 3.034 |
| Free Cash Flow | 174.3 | 2,153 | 916.9 | - | - | - | - | - |
| FCF margin | 3.76% | 32.01% | 13.3% | - | - | - | - | - |
| FCF Conversion (EBITDA) | 18.03% | 96.83% | 47.84% | - | - | - | - | - |
| FCF Conversion (Net income) | 23.16% | 122.4% | 61.85% | - | - | - | - | - |
| Dividend per Share 2 | 0.4000 | 0.3000 | 0.3000 | 0.6000 | 0.8000 | 0.7600 | 0.7275 | 1.030 |
| Announcement Date | 2/28/20 | 1/28/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 2,277 | 1,683 | 1,309 | 2,231 | 2,282 | 2,060 | 2,616 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
| Net income | 713.5 | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| EPS | 0.7186 | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 4/28/23 | 8/28/23 | 10/24/23 | 4/26/24 | 4/26/24 | - | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | 1,413 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | 174 | 2,153 | 917 | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 13.1% | 26.2% | 19.2% | 17.5% | 22.5% | 16.8% | 16.6% | 16.8% |
| ROA (Net income/ Total Assets) | 10% | 19.5% | 13.4% | 11.8% | - | 13.3% | 12.5% | 13.8% |
| Assets 1 | 7,495 | 9,015 | 11,032 | 13,547 | - | 17,076 | 20,815 | 22,029 |
| Book Value Per Share 2 | 6.060 | 7.420 | 8.250 | 9.840 | 11.70 | 13.40 | 15.70 | 18.10 |
| Cash Flow per Share 2 | 0.6100 | 2.820 | 1.200 | 2.300 | 2.120 | 1.950 | 2.450 | 2.860 |
| Capex 1 | 440 | 678 | 284 | 178 | - | 328 | 311 | 242 |
| Capex / Sales | 9.49% | 10.08% | 4.11% | 2.5% | - | 3.72% | 3.01% | 2.12% |
| Announcement Date | 2/28/20 | 1/28/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
39.66
CNY
Average target price
47.79
CNY
Spread / Average Target
+20.49%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +14.69% | 5.5B | |
| +73.46% | 12.41B | |
| -15.61% | 8.23B | |
| +3.88% | 6.46B | |
| -7.00% | 5.33B | |
| +42.58% | 5.1B | |
| -18.32% | 4.05B | |
| -32.61% | 2.54B | |
| +10.80% | 1.99B | |
| -1.11% | 1.99B |
- Stock Market
- Equities
- 002223 Stock
- Financials Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.